{"id":57972,"date":"2024-08-06T00:03:57","date_gmt":"2024-08-06T00:03:57","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/06\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/"},"modified":"2024-08-06T00:03:57","modified_gmt":"2024-08-06T00:03:57","slug":"belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/","title":{"rendered":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results"},"content":{"rendered":"<div>\n<p align=\"justify\">SAN DIEGO, Aug.  05, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BL1DSS1zHJd7DKTwMxb7dj2MsdZiQRU2oL2Y5HMRPHCvHcn5xrOWFSIsjwIiy7je4Hvl8QK_SXtcuvCT4O-d0w==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Belite Bio\">Belite Bio<\/a>, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, August 12, 2024, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the second quarter ended June 30, 2024.<\/p>\n<p align=\"justify\"><strong>Webcast Information<\/strong><br \/><strong>Date: <\/strong>Monday, August 12, 2024 <br \/><strong>Time: <\/strong>4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EWsAeIKQeJtnh-uQfh2exllgucQSQ1DwYXn63vxG3s-AezpQbO50kHPjIZzyQwps8IQ4hPhIFn7wrMeCKhombI-PCPSJfNJnJiW9rALWpPWFEilFrlBrD1zF6izm25Ob0SXxRO8amuBwJTKtQLoU9A==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/wsw.com\/webcast\/cc\/blte4\/1422018<\/a><\/p>\n<p align=\"justify\"><strong>Webcast Link Instructions<\/strong><br \/>You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EWsAeIKQeJtnh-uQfh2exoOlKYz5pcRJAiO3jFSzSeGIEvfB-_ikYSaqme_-6BEIrBix4iQkYwFOfzhg-qsYWgWMNGOcbISaMQebwJE4v9uT8C_pa0NJOs6i3skeOIuQ47YeeihCCuU9XVZb2JYVkyXdwV1EFpIocX5eWuj2i7banqf1BwZ76CORv0rVzzK7cSr6IdfuuAof-Gl1nrANV-NFOqqq2cj-21TdT8z2N433TL0F6ddnhiwIvhO2k1oM5K3QKRyW4cJwgp4nePunU3E4FxapehN0U-fCiuxAhA_bz4bhRMzw-QVBLCN-KSNwNqTPBWuO88TLjfB9EPX5jEL6TKs6IDse97XwI6KHKHdO72yMUV0IF2vcY1d8qQdGiOo6wJBjwLjLIKEc09APpiKr1PZ9tpM-60VlmPJvAoc=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/investors.belitebio.com\/presentations-events\/events<\/a>. A replay will be available for approximately 90 days after the event.<\/p>\n<p align=\"justify\"><strong>About Belite Bio<\/strong><br \/>Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, such as Stargardt Disease type 1 (STGD1) and Geographic Atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite\u2019s lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of toxins in the eye, is currently being evaluated in a Phase 3 study (DRAGON) and a Phase 2\/3 study (DRAGON II) in adolescent STGD1 subjects and a Phase 3 study (PHOENIX) in subjects with GA. For more information, follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a36K4-MsPUy7CpTBryqE8HP9040rWVGBk4x8cuaHpk5bCgykVN4g_d7jzwBvrMsec5msUsM3hx0B8ediD2LoiLgI44S_3At8ekhz8eRV6W2Usnxwqxs9f1iUinZVMM_8UtZ7FrqwgOPQNdVXMtCDReRK6dnTnNxqgwJrjDlNKFQ2U7arDF3U1-l4QZnwcl3CHJwGIRAhUf_vvWRSyQbOdFisKvvN9QYKIewSY_1KwQVTtBXFL_9ovOVxZyqY3wQ-NKddvuSC7uhWLk1CswG9v9MhxxI6ipV-QCRk4xHx0hgx10vzCM1o10C3mREMUIektKt_uC8RCepGIqENBI-5BZN2Mdnf8O0gaewaPPQZw8zOKwyeRnmeVCPj-W8GlgbzXZCWINJReKdIYe3iO-_rr90OtEOn9caIcf3FY8BtPI9DZiOSn9nqPXhIWGWOV0fxFOdKm_DPMssm193rxYYV17csiWhrdrWVWaP4PMIKQFq-qerzmtqOSOyB03S2waMKu26SvlL95CkdkcR3ya8r0aNXtV7DI4NLMIG5M3pQiEd_NkVSh_YKdOcyRZ2zwAFeiGVBxIzfKxET6oOI1QwuOLBILN3AGMp5XMPHi4eYKtEhDauXiDfvG0lT2B7VUWS59fuAv-Be4zS6wE4i6rMwV2L027wWYKYttt0hzpYWqF0=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Twitter\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MjPhCd_ExTbK24uYwTz4JybJFynKkY_UJ8U8rAbtVZ-wTkp2HeMU3Xfo-RZH_csdLeS5184_eIeRajVyQThoX8KARwMFweqmFQRWMNzeaUgJ0Mv2XVMhz7JgY9PQjjqrtljWW81DoDR-k5Im_J0lX1Z9CNDZ7_mqUPEf_3MGqNa13fyKd6e7CV12cyy2UWnxgXBnHk4ja7hq7yKPaNIbDAacUmIoFaIzZwyaGekRB_dzHcUe13kZYbGGGBRSR9L5i8i9OvKA1hpcj8DebsFn-h8bXTGQQLb9R7K6IS1yWi1PXT9tc1XLqPvYKmMGugDckahZ275y8txxgSDTpgQGm3DD-i50o_S9CKA7W3rWErkKA0TrSuRNyU90rr525jHc0--INnIlnHflPqwvMhphsdDOQAfbMDd_xy7dMzpRL1ezN7bwqlwBZmgvhFqlL-neCWTP-nZv6fM0Q0GTtX7MksXEdSw_lTwktOXaTIUYgNJFcpHlIcv9fNh8xCGloj_yc5kCXH6gFbAvYZCFujeFzZdqSKRYBDjaAuUEOqs7GTJD6TX_T2Xsm_Ay3ymX5PPu5KxIZt9nZE_ozTvg2E2hMoOy8XChIAX8FxbntSdE80nhsHQ2yAmIpXoxuGjJtzxmssgn8K8OYpy2ye4ijqBa55-S4tYv2f52XFzlwuVdiRd-G-x16kKCIEN0hd1gCKGn\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Instagram\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B4TGNObnwYkluXvviTwpjmRRTbm1sMuwu443JzvRdfCgP50gD0LImKNhFJN5cPZ1n_c7odZpLbxqsO9IuKdUCDdYiGxbqRie6rw_zlLQIeraQXUD0XXSjpGcb5wMY9mLf6vw-hX6cHokeHXSxBRaEnN2tr1A8yKo6nAmTcCRmHouyVEENMSr9YyZnNifwWtStyWusVRggS-UoIlBSIKvHjEzShURhh2KyHkLsrAgh6zsSJYjbimrVbmJW1Usx9uuwD8UBTQ46JI8WPuNUXOCeTrBB1XTpk5cPH2XNSvIsBycXSZhxay1TYVILBndPHpL-x3SOcOeeo7-iQK9M7_4Vd0jkG_765BP_PY4bPaCG6YAJya68FbX_dyE6y3GaNWkgCghwxQOtfDwcttH0E02U7f7_IYNTLKVD1sa0pMqcJevWSaefooL7MR12Lh5UMvRB-kKLJawZ8O6UKap4ez9-9EkM3SwuE8njfYOqRKvw-CY0ZdGl5PcJ_126GLrYNbWgXSszOQ2-atT6CfxG_ikSANq7uGsMOYg5Gy4SwkMTGLi6z96kdsih_NYMJqpoNLduEuP6kzZ0fWXyluVKaE5Lk3mVfZ_DvzwmvgbKYSvMkO7CObsQuRzMli6h7tBxbIM1RVOaw7qA_4zNiD5fYFYrkDFCiOaFjyymNInuAUKNhBz7YGgayW7h_IGfre_ZqMy\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F9ps73W8Z37_-YQZYQTwUZMloN1OqNaVYaVp5ew0fWCzNzequC5pVapPeYiFSNyoXaunVUwtWZA1vYBgsL3___1v4HbQUAzTGBt4dEpwqVhzsFIEzlH85YWsl-YvqB4-Mg-wd6zPc280GFJ6PtnjC7F0iLDk3_L0xivR9dWsQj5eOOADfiMW2eBRjFNck7A0yp9nsK59XhouS5jpATF9Pw9UMTqmjwLuZVkOv7q0LLmim_4Kjtu9UWJXgDQci1eRqk_wDNknruzxF6m8mXynjTlRxQ4HUTO43_SL4RqIyB70H_D4F5BUdEXQkeV5MkkeTCmb3Xta9NvTvwqGYFa-AY6yb_KodWB9wL0vObDwhKcNhsBScnYPiDuhURdLYcuLYYxMA__r3fEBHZ2JOalGdCnBzzbH1zpeq7BuIGAi7CZYgWvbEdy5Ib-eo8QiBR-i2--wmFZpF3xqoyC8ng2Oq8lz_lBjFFmHGMG3xa5_18aIZM_rWLsqwgY8dIYugrL7VS2UvMi6c1uVYDbZWGAkCKiH6svQrJ-u5-zHKaFRYbDer96FHbSg-PNMpfPxKsHYDdn5CqIoXHp3bYsvYBhDgIqeOTvwqQY3SuUblwLsTgkvIzNqQsst1s5CDTrB7Cq_QPidObalSLGVlQRI4xHRG4Gi0Qqa5bk5Z0-uFrB_QjPYufRiv7FIibLOgrzGe6r9Aj32IWHVINZakhT7NGDmZ7xHI7GOQ0F91Ua45fD3N4rhzOzip6DR_RQeUXJ_W-ee\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Facebook\">Facebook<\/a>, or visit us at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7bp5MK5NjH7qAe5rKuikDT4s44kjdqoJsnhR2w7rGASk-h_6qqWGkg4HPi7i99MIoLvZyz5sJolr8LUZ05jkYP_CuMpqxBqkHQ0INVKsjlRGYMmIJOgTxrvJQIkUWqX8XzHStTLX_HTtlVLyN9OXV_eTvqVnXpnR75JedLdRqrfqYAvz2yVeVnaX3DIllE5TkTufN-tdmJM4MU6zPBhovUEErVAsENKh4g_ucr7uxRp1OpqziS9gF52tmzw6lSK_yIyNMhIRb4UsjrfJgyA1mR1KQb4z8-Yh49SflYFU0zUkllGqvGHbH2pKcGh6nMWNttZL7NUXR-fVE4lv3GW9SiuIBKl5WP_sNXD0M5vpbEZW33LoAzZ1t97HgsO6QAFu4CQuMXIeAS6YGjD6BRt5fTFJ_fU2QEhFFnBzYVVnBz_QvelyPOvqCSON_ngKnbyL6HxElwXwvYTfJo87lvKFbCy1AlvNkyjX0KmfGVKJhjCby9HjaA7cKkhHKXAbjk_bALjAo3zy3SS9pOVUFVsvxwk_d4kyj1_bkw3xp8UuRNm0trtsHGFfhQHdnibfY5hQJb8eWl_nM46GYAoRzfS6wcD9sOGSgKrN6NHtoMa_n47nqxwsRf2-lyPAGXUpUEJAKdWEpbZPlHxHdayRl24XTTZf5pL_p2xuXTbskuvofLnwqgk3SRUzc52Hs7ZWprwnmQNRKps1Cb-JM2KZUek9_dzH6p287McnRX4WfYYxkpo=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.belitebio.com\">www.belitebio.com<\/a>.<\/p>\n<p><strong>Media and Investor Relations Contact:<\/strong><br \/>Jennifer Wu <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mGQqlcAxuWsDiUH2M0W36wx7J0fQOxn90qJ8Miin9hd_E_qCtYq6BLhxF5jM0AHgAiDfd1DC8o6dzKwpgzG2bw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"ir@belitebio.com\">ir@belitebio.com<\/a><\/p>\n<p>Julie Fallon<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nx-eNCqdh2QRPAI-HdakcDHW9d787ThyfDK4CtI9D6UieIS4Zhn6sGao2av4m4tVStpdF1IoCaKL72hKlwQ6RuhiEPUceG7KGibp6sFXcFw=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"belite@argotpartners.com\">belite@argotpartners.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjYzNzY1MzMtMWRmNS00MTU0LWJjOTQtODMwMDYzYzQzNDM3LTEyNDUyODU=\/tiny\/Belite-Bio-Inc.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, August 12, 2024, at 4:30 p.m. Eastern Time to discuss the [&#8230;]\n","protected":false},"author":1,"featured_media":57973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-57972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-06T00:03:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/Belite-Bio-Inc.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results\",\"datePublished\":\"2024-08-06T00:03:57+00:00\",\"dateModified\":\"2024-08-06T00:03:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\"},\"wordCount\":274,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\",\"name\":\"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-08-06T00:03:57+00:00\",\"dateModified\":\"2024-08-06T00:03:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results","og_description":"SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused","og_url":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-08-06T00:03:57+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/Belite-Bio-Inc.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results","datePublished":"2024-08-06T00:03:57+00:00","dateModified":"2024-08-06T00:03:57+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/"},"wordCount":274,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/","url":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/","name":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-08-06T00:03:57+00:00","dateModified":"2024-08-06T00:03:57+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/belite-bio-to-host-webcast-on-august-12-2024-to-discuss-second-quarter-2024-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/57972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=57972"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/57972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/57973"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=57972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=57972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=57972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}